MedTrace Logo

Impact of Prokinetic Use After Emergency Intestinal Anastomosis on Postoperative Clinical Outcomes

NCT05290753 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-05-03

No results posted yet for this study

Summary

Prokinetic drugs used to accelerate healing of intestinal anastomosis of urgent cases which not prepared preoperative by increase intestinal motility and gastric emptying and decrease postoperative adhesions They are many types of prokinetics as cholinergic agonists, dopamine antagonist, serotonergic agonists and macrolides Agents of prokinetics administered immediately post operation and at the time of hospitalization

Conditions

  • Prokinetic Use After Emergency Intestinal Anastomosis

Interventions

DRUG

Prokinetic Motility Agents as primpiram and gastreg

Prospective cohort study to evaluate the effect of pro kinetic use in emergency intestinal anastomosis

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Alaa eldin Hassan, Professor · Professor of general surgery

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-01
Completion
2022-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05290753 on ClinicalTrials.gov